Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Category:

Medications for the Masses? Pharmacogenomics is an Important Public Health Issue

Adverse drug events are a serious public health problem. Consider the following facts: an estimated 82% of American adults take at least one medication and 29% take five or more; 700,000 emergency department visits and 120,000 hospitalizations are due to adverse drug events annually; $3.5 billion is spent on extra medical costs of adverse drug Read More >

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention3 CommentsTags , , ,

What are the Priorities for Public Health Genomics 2012-2017?

Since 1997, the Office of Public Health Genomics (OPHG) at the Centers for Disease Control and Prevention (CDC) has worked to integrate genomics into public health research, policy, and programs. Our driving force is to improve interventions designed to prevent and control the country’s leading chronic, infectious, environmental, and occupational diseases. OPHG’s efforts focus on conducting Read More >

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention1 CommentTags , ,
TOP